Unilife Corp. (NASDAQ:UNIS) shares traded down 2.3% on Friday . The stock traded as low as $2.47 and last traded at $2.54, with a volume of 65,219 shares traded. The stock had previously closed at $2.60.

The firm has a 50-day moving average of $3.07 and a 200 day moving average of $4.61. The firm’s market capitalization is $42.81 million.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in UNIS. Paloma Partners Management Co purchased a new position in Unilife Corp. during the second quarter worth about $171,000. Geode Capital Management LLC increased its position in Unilife Corp. by 39.6% in the first quarter. Geode Capital Management LLC now owns 1,020,300 shares of the company’s stock worth $693,000 after buying an additional 289,367 shares in the last quarter. Goldman Sachs Group Inc. increased its position in Unilife Corp. by 0.7% in the first quarter. Goldman Sachs Group Inc. now owns 364,873 shares of the company’s stock worth $248,000 after buying an additional 2,539 shares in the last quarter. State Street Corp increased its position in Unilife Corp. by 1.7% in the first quarter. State Street Corp now owns 1,833,005 shares of the company’s stock worth $1,244,000 after buying an additional 31,104 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in Unilife Corp. by 2.9% in the first quarter. JPMorgan Chase & Co. now owns 16,402,381 shares of the company’s stock worth $11,155,000 after buying an additional 468,192 shares in the last quarter. Hedge funds and other institutional investors own 16.52% of the company’s stock.

Unilife Corp. Company Profile

Unilife Corporation is a medical device manufacturer and component supplier. The Company is engaged in the designing, development and manufacturing of injectable drug delivery systems. It has a portfolio of product platforms, including pre-filled syringes, wearable injectors, insulin delivery systems, disposable and reusable auto-injectors, drug reconstitution delivery systems, ocular delivery systems and other systems.

5 Day Chart for NASDAQ:UNIS

Receive News & Ratings for Unilife Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unilife Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.